GSK plc (NYSE:GSK) on Wednesday announced plans to invest $30 billion across the United States in research and development and supply chain infrastructure over the next five years. The update includes ...

GSK has agreed to acquire RAPT Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing novel ...

GSK (GlaxoSmithKline Plc) is ramping up its US presence with a multi-billion-dollar plan to expand research and development (R&D) and manufacturing capabilities across the country. “Today, we are ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Pennsylvania is providing GSK ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other best ...

INCHEON, South Korea, ROCKVILLE, Md. and LONDON , Dec. 21, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing ...

GSK plans to invest $30 billion on research, development and supply chain infrastructure in the U.S. over the next five years. The plan includes $1.2 billion for new manufacturing facilities and ...

As GSK weathers the storm of sinking vaccine sales and gears up for key launches in its specialty medicines sector, the British drug giant feels prepared for any challenges that U.S. drug import ...

Secures the company's first U.S.-based manufacturing site, strengthening and diversifying its global supply network Additional investments planned to expand the site's capacity (currently at 60,000 ...